You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CLL/CPL

Showing 26 - 50 of 761
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Japan (Venetoclax, Ibrutinib, Obinutuzumab)

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • Nagoya-shi, Aichi, Japan
  • +19 more
Jan 25, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the (Acalabrutinib (Arm A), Acalabrutinib (Arm B))

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Acalabrutinib (Arm A)
  • Acalabrutinib (Arm B)
  • Bethesda, Maryland
    Research Site
Jan 3, 2023

ITGA4 Gene Methylation Status in Chronic Lymphocytic Leukemia

Not yet recruiting
  • Chronic Lymphocytic Leukemia
    • (no location specified)
    May 7, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Acalabrutinib, Obinutuzumab)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 14, 2022

    CLL/SLL Trial in Wuhan, Changsha (Orelabrutinib and BG)

    Not yet recruiting
    • CLL/SLL
    • Orelabrutinib and BG
    • Wuhan, Hubei, China
    • +1 more
    Jun 15, 2023

    Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma Trial in India (Acalabrutinib capsule)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma
    • Acalabrutinib capsule
    • Ahmedabad, India
    • +12 more
    Feb 2, 2023

    Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in France, Germany, United States (Odronextamab multiple dose levels)

    Recruiting
    • Non-Hodgkin Lymphoma
    • Chronic Lymphocytic Leukemia
    • Odronextamab multiple dose levels
    • Orange, California
    • +20 more
    Dec 14, 2022

    Study of the Metabolism in the Lymphatic Niche of CLL

    Recruiting
    • CLL
    • NO intervention
    • Nice, France
      Nice University Hospital
    Nov 2, 2022

    Healthcare Resources in Chronic Lymphocytic Leukemia Initiating

    Completed
    • Chronic Lymphocytic Leukemia
      • Calgary, Alberta, Canada
      • +12 more
      Jul 7, 2022

      Multiple Myeloma (MM), DLBCL, Not Otherwise Specified, Double Hit Lymphoma Trial in Spain (IDP-121)

      Recruiting
      • Multiple Myeloma (MM)
      • +5 more
      • Santander, Cantabria, Spain
      • +4 more
      Jun 19, 2023

      Uncontrolled Type 2 Diabetes Trial in India (CPL-2009-0031 140 mg, Sitagliptin 100mg)

      Completed
      • Uncontrolled Type 2 Diabetes Mellitus
      • CPL-2009-0031 140 mg
      • Sitagliptin 100mg
      • Nellore, Andhra Pradesh, India
      • +11 more
      Aug 14, 2021

      Chronic Lymphocytic Leukemia (CLL) Trial

      Completed
      • Chronic Lymphocytic Leukemia (CLL)
        • (no location specified)
        Apr 5, 2022

        Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

        Recruiting
        • Relapsed or Refractory CD19+ B-cell Lymphoma
        • +2 more
        • TBI-2001
        • +2 more
        • Toronto, Ontario, Canada
          Princess Margaret Cancer Centre
        Jul 26, 2023

        Follicular B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Recurrent, Mantle Cell Lymphoma Refractory Trial in Orange,

        Recruiting
        • Follicular B-cell Non-Hodgkin's Lymphoma
        • +7 more
        • MB-106
        • Orange, California
        • +3 more
        Nov 1, 2022

        Adult Chronic Lymphocytic Leukemia Receiving Oral Venetoclax

        Recruiting
        • Chronic Lymphocytic Leukemia
          • London, London, City Of, United Kingdom
          • +9 more
          Jan 13, 2023

          Warm Autoimmune Hemolytic Anemia Trial in Beijing (Zanubrutinib)

          Not yet recruiting
          • Warm Autoimmune Hemolytic Anemia
          • Beijing, Beijing, China
            Peking Union Medical College Hospital
          Jun 20, 2023

          B Cell Repertoires in Chronic Lymphocytic Leukemia and Aging

          Active, not recruiting
          • Chronic Lymphocytic Leukemia
            • Manhasset, New York
              Feinstein Institute for Medical Research
            Jul 6, 2022

            Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Duarte (procedure, biological, drug)

            Not yet recruiting
            • Chronic Lymphocytic Leukemia
            • Small Lymphocytic Lymphoma
            • Biospecimen Collection
            • +4 more
            • Duarte, California
              City of Hope Medical Center
            Jan 30, 2023

            CLL/SLL Trial in France (First line therapy)

            Not yet recruiting
            • CLL/SLL
            • First line therapy
            • Amiens, France
            • +57 more
            Oct 21, 2022

            Recurrent Chronic Lymphoid Leukemia Trial in Boston (ACY-1215, Ibrutinib, Idelalisib)

            Active, not recruiting
            • Recurrent Chronic Lymphoid Leukemia
            • Boston, Massachusetts
              Dana Farber Cancer Institute
            Dec 19, 2022

            Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Venetoclax, Obinutuzumab)

            Recruiting
            • Chronic Lymphocytic Leukemia (CLL)
            • La Jolla, California
            • +41 more
            Aug 10, 2022

            Leukemia, Chronic Lymphatic Trial in Stuttgart, Tuebingen (Peptide Vaccine, Imiquimod)

            Completed
            • Leukemia, Chronic Lymphatic
            • Stuttgart, Baden-Wuerttemberg, Germany
            • +4 more
            Nov 24, 2022

            Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Pirtobrutinib, Venetoclax)

            Recruiting
            • Chronic Lymphocytic Leukemia
            • Small Lymphocytic Lymphoma
            • Houston, Texas
              M D Anderson Cancer Center
            Nov 17, 2022

            Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome Trial in Italy, United Kingdom, United States

            Active, not recruiting
            Has Results
            • Chronic Lymphocytic Leukemia
            • +3 more
            • Boston, Massachusetts
            • +11 more
            Nov 23, 2022

            Biomarker for Infection Risk in CLL and MM

            Not yet recruiting
            • Multiple Myeloma
            • Chronic Lymphocytic Leukemia
            • Screening
            • Boston, Massachusetts
              Massachusetts General Hospital Cancer Center
            May 3, 2023